Scholarlink

<p>A series of 3-substituted oxindole derivatives <b>3a-j</b> was synthesized. The target compounds <b>3a-j</b> were investigated for their potential antibacterial and antifungal activities. <i>S. aureus, MRSA, E. faecalis, P. aeruginosa, K. pneumonia,</i> and <i>E. coli</i> were used for testing the antibacterial activity, while <i>Candida albicans and Aspergillus spp,</i> were used for antifungal activity of the tested compounds. Compounds <b>3i</b> and <b>3j</b> exhibited the strongest activity, particularly against Gram-positive bacteria. Antifungal activity was tested against <i>Aspergillus spp</i>. and <i>Candida albicans</i> using the agar diffusion method, with a final concentration of 10,000&#xa0;µg/mL per well. Eight compounds inhibited <i>Aspergillus spp.,</i> while only compound <b>3g</b> was active against <i>C. albicans</i>. Compound <b>3f</b> displayed the highest antifungal activity (inhibition zone = 20&#xa0;mm) compared with itraconazole with a final concentration of 100&#xa0;µg/mL per well (30&#xa0;mm). Minimum inhibitory concentration (MIC) testing confirmed compound <b>3f</b> as the most potent antifungal, with an MIC of 7.5&#xa0;µg/mL against <i>Aspergillus niger</i>, lower than that of clotrimazole (12.5&#xa0;µg/mL). Further investigations showed that compound <b>3f</b> exerted its effect by disrupting fungal cell wall integrity without binding ergosterol. Docking studies of compound <b>3f</b> in the active sites of chitin deacetylase AngCDA (PDB ID: 7BLY) and the 1,3-β-glucan synthase (8JZN) enzymes proved its dual-target mechanism ability to inhibit the cell wall biosynthesis. These findings highlight compound <b>3f</b> as a promising lead scaffold for the development of new antifungal agents targeting fungal cell wall biosynthesis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antimicrobial activity and antifungal mechanistic study of 3‑substituted oxindoles against Aspergillus niger

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月29日

查看全文
  • Hend A. A. Ezelarab,
  • Maisra M. El-Bouseary,
  • Ramadan Yahia,
  • Rehab Mahmoud Abd El-Baky,
  • Mohamed A. Mawhoup,
  • Eman Farouk Ahmed,
  • Ghada M. Sadiq,
  • Taha F. S. Ali,
  • Samar H. Abbas,
  • Heba A. Hassan,
  • Eman A. M. Beshr

摘要

A series of 3-substituted oxindole derivatives 3a-j was synthesized. The target compounds 3a-j were investigated for their potential antibacterial and antifungal activities. S. aureus, MRSA, E. faecalis, P. aeruginosa, K. pneumonia, and E. coli were used for testing the antibacterial activity, while Candida albicans and Aspergillus spp, were used for antifungal activity of the tested compounds. Compounds 3i and 3j exhibited the strongest activity, particularly against Gram-positive bacteria. Antifungal activity was tested against Aspergillus spp. and Candida albicans using the agar diffusion method, with a final concentration of 10,000 µg/mL per well. Eight compounds inhibited Aspergillus spp., while only compound 3g was active against C. albicans. Compound 3f displayed the highest antifungal activity (inhibition zone = 20 mm) compared with itraconazole with a final concentration of 100 µg/mL per well (30 mm). Minimum inhibitory concentration (MIC) testing confirmed compound 3f as the most potent antifungal, with an MIC of 7.5 µg/mL against Aspergillus niger, lower than that of clotrimazole (12.5 µg/mL). Further investigations showed that compound 3f exerted its effect by disrupting fungal cell wall integrity without binding ergosterol. Docking studies of compound 3f in the active sites of chitin deacetylase AngCDA (PDB ID: 7BLY) and the 1,3-β-glucan synthase (8JZN) enzymes proved its dual-target mechanism ability to inhibit the cell wall biosynthesis. These findings highlight compound 3f as a promising lead scaffold for the development of new antifungal agents targeting fungal cell wall biosynthesis.